Fifteen million people on antiretroviral treatment by 2015: treatment as prevention

被引:35
作者
Granich, Reuben [1 ]
Williams, Brian [2 ]
Montaner, Julio [3 ]
机构
[1] UNAIDS, Geneva, Switzerland
[2] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa
[3] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada
基金
美国国家卫生研究院; 比尔及梅琳达.盖茨基金会; 加拿大健康研究院;
关键词
HIV; treatment as prevention; tuberculosis; SUB-SAHARAN AFRICA; CD4 CELL COUNTS; SEXUAL RISK BEHAVIOR; HIV-INFECTED ADULTS; VIRAL LOAD; MALE CIRCUMCISION; PATIENT RETENTION; UNIVERSAL ACCESS; DRUG-RESISTANCE; THERAPY;
D O I
10.1097/COH.0b013e32835b80dd
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The declaration of the United Nations High Level meeting on AIDS in June 2011 includes 10 concrete targets, including to ensure that there are 15 million people living with human immunodeficiency virus (HIV) on antiretroviral treatment (ART) by 2015. This review examines the potential, opportunities and challenges of treatment as prevention of HIV and tuberculosis (TB) in reaching this target. Recent findings Although around 8 million people are on treatment, everyone living with HIV will eventually need ART to stay alive. As many as 24 million people living with HIV today are not on treatment, the majority not even being aware of their HIV infection. Expansion of a comprehensive prevention strategy including providing ART to 15 million or more people would significantly reduce HIV and TB morbidity, mortality and transmission. The challenges include ensuring human rights protections, steady drug supply, early diagnosis and linkage to care, task shifting, adherence, retention, and monitoring and evaluation. Expansion could also lead to the control and possible elimination of HIV in many places. Summary Achieving an 'AIDS-free generation' whereby deaths related to HIV are drastically reduced, people living with HIV are AIDS-free on ART, and HIV transmission is decreased, is both scientifically sound and practically feasible. The global community could reach 15 million people on ART by 2015 while expanding our vision and efforts to include diagnosis and treatment for all the 32 million people living with HIV in the future.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 85 条
[51]   Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection-A Quantitative Review [J].
Korenromp, Eline L. ;
Williams, Brian G. ;
Schmid, George P. ;
Dye, Christopher .
PLOS ONE, 2009, 4 (06)
[52]   Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection [J].
Kuller, Lewis H. ;
Tracy, Russell ;
Belloso, Waldo ;
De Wit, Stephane ;
Drummond, Fraser ;
Lane, H. Clifford ;
Ledergerber, Bruno ;
Lundgren, Jens ;
Neuhaus, Jacqueline ;
Nixon, Daniel ;
Paton, Nicholas I. ;
Neaton, James D. .
PLOS MEDICINE, 2008, 5 (10) :1496-1508
[53]  
Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72
[54]   Partners at risk: motivations, strategies, and challenges to HIV transmission risk reduction among HIV-infected men and women in Uganda [J].
Lifshay, Julie ;
Nakayiwa, Sylvia ;
King, Rachel ;
Reznick, Olga Grinstead ;
Katuntu, David ;
Batamwita, Richard ;
Ezati, Enoch ;
Coutinho, Alex ;
Kazibwe, Cissy ;
Bunnell, Rebecca .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (06) :715-724
[55]   Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic [J].
Lima, Viviane D. ;
Johnston, Karissa ;
Hogg, Robert S. ;
Levy, Adrian R. ;
Harrigan, P. Richard ;
Anema, Aranka ;
Montaner, Julio S. G. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (01) :59-67
[56]   Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique [J].
Lio, Massimo Magnano San ;
Carbini, Riccardo ;
Germano, Paola ;
Guidotti, Giovanni ;
Mancinelli, Sandro ;
Magid, Noorjehan Abdul ;
Narciso, Pasquale ;
Palombi, Leonardo ;
Renzi, Elsa ;
Zimba, Ines ;
Marazzi, Maria Cristina .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (10) :1609-1616
[57]   Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines [J].
Lodi, Sara ;
Phillips, Andrew ;
Touloumi, Giota ;
Geskus, Ronald ;
Meyer, Laurence ;
Thiebaut, Rodolphe ;
Pantazis, Nikos ;
del Amo, Julia ;
Johnson, Anne M. ;
Babiker, Abdel ;
Porter, Kholoud .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (08) :817-825
[58]   Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the US Military HIV Natural History Study [J].
Marconi, Vincent C. ;
Grandits, Greg A. ;
Weintrob, Amy C. ;
Chun, Helen ;
Landrum, Michael L. ;
Ganesan, Anuradha ;
Okulicz, Jason F. ;
Crum-Cianflone, Nancy ;
O'Connell, Robert J. ;
Lifson, Alan ;
Wortmann, Glenn W. ;
Agan, Brian K. .
AIDS RESEARCH AND THERAPY, 2010, 7
[59]   Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection [J].
Mellors, JW ;
Munoz, A ;
Giorgi, JV ;
Margolick, JB ;
Tassoni, CJ ;
Gupta, P ;
Kingsley, LA ;
Todd, JA ;
Saah, AJ ;
Detels, R ;
Phair, JP ;
Rinaldo, CR .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :946-954
[60]   Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men [J].
Mills, E. ;
Cooper, C. ;
Anema, A. ;
Guyatt, G. .
HIV MEDICINE, 2008, 9 (06) :332-335